CDKN2A and malignant peripheral nerve sheath tumor: It has been shown that loss of CDKN2A is correlated with ANNUBP [23] and further loss of PRC2 components, TP53, or other alterations are likely to drive the malignant transformation from ANNUBP to MPNST [24,25,26].